MNA
TEVA icon

Manning & Napier Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Manning & Napier Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
86
+43
+100% +$1.43K ﹤0.01% 681
2026
Q1 		$1.22K Sell
43
-1
-2% -$32 ﹤0.01% 573
2025
Q4 		$1.38K Buy
+44
New +$1.08K ﹤0.01% 500
2017
Q2 		– Sell
-96,678
Closed -$3.1M – 348
2017
Q1 		$3.1M Buy
96,678
+12,645
+15% +$432K 0.02% 251
2016
Q4 		$3.04M Sell
84,033
-29,403
-26% -$1.17M 0.02% 242
2016
Q3 		$5.22M Sell
113,436
-2,866
-2% -$150K 0.03% 190
2016
Q2 		$5.84M Buy
116,302
+5,110
+5% +$272K 0.04% 182
2016
Q1 		$5.95M Sell
111,192
-2,031
-2% -$119K 0.03% 176
2015
Q4 		$7.43M Sell
113,223
-222,570
-66% -$13.8M 0.04% 154
2015
Q3 		$19M Sell
335,793
-720
-0.2% -$46.7K 0.1% 97
2015
Q2 		$19.9M Buy
336,513
+25,090
+8% +$1.55M 0.09% 108
2015
Q1 		$19.4M Buy
311,423
+18,335
+6% +$1.07M 0.09% 115
2014
Q4 		$16.9M Sell
293,088
-86
-0% -$4.79K 0.07% 124
2014
Q3 		$15.8M Buy
293,174
+28,209
+11% +$1.49M 0.07% 136
2014
Q2 		$13.9M Buy
264,965
+33,713
+15% +$1.72M 0.05% 147
2014
Q1 		$12.2M Sell
231,252
-237
-0.1% -$11K 0.05% 153
2013
Q4 		$9.28M Sell
231,489
-23,467
-9% -$924K 0.04% 159
2013
Q3 		$9.63M Buy
254,956
+3,438
+1% +$134K 0.05% 161
2013
Q2 		$9.86M Buy
+251,518
New +$9.79M 0.05% 157

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Manning & Napier Advisors's TEVA Position: Q2 2026 in Review

Manning & Napier Advisors increased its Teva Pharmaceuticals (TEVA) stake by 100% in Q2 2026, buying an estimated $1.43K and bringing the position to 86 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Manning & Napier Advisors first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $19.9M in Q2 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Manning & Napier Advisors held 86 shares of Teva Pharmaceuticals worth $2.87K as of Q2 2026.
  • Manning & Napier Advisors bought 43 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.43K.
  • Teva Pharmaceuticals made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #681 holding.
  • Manning & Napier Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • Manning & Napier Advisors's Teva Pharmaceuticals position peaked at $19.9M in Q2 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.